The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024
Listed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 2) 2024 - external site, which commenced on 14 June 2024. This determination replaces the previous instrument, the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2024.
This instrument is updated frequently and there may be a more recent version of the instrument. Ensure you are accessing the current version of the instrument through the Therapeutic Goods Determination page.
A complete list of the 9 changed ingredients is below:
Changed ingredients
| Substance name | Change |
|---|---|
| Bacillus subtilis | Addition |
| behentrimonium metilsulfate | Addition |
| D-glucose, polymer with xylitol | Addition |
| 1,8,12-bisabolatriene | Addition |
| polyglyceryl-2 isostearate | Addition |
| beeswax alcohols | Change |
| Euglena gracilis whole cell dry | Change |
| Litchi chinensis | Change |
| nonivamide | Change |